OFFICE NO 5 & 6, 3RD FLOOR,
EARTH ALPHA COMPLEX
VASNA BHAYLI RD, VADODARA
GUJARAT, INDIA
Zircon Medtech is young, energetic, emerging pharmaceutical enterprise established by small group of highly passionate pharmaceutical professionals who has cumulative experience of more than 20 years in the field of international as well as domestic pharmaceutical business
We are manufacturer, exporter & marketer of world class quality branded generic & generic medicine, located at Vadodara, City of Gujarat State, India.
We offer contract manufacturing & In/Out licensing partnership model to our customers. We are also open for other partnership model based upon customer’s requirement.
We endeavour to become a leading global healthcare provider by continuously challenging ourselves to highest standards of performance and compliance.
To serve mankind with quality products & medicines at affordable prices with global standards
Our 20+ years of experience helps us provide the best quality products for the betterment of our client.
Efficient team is required to bridge the gap between the Buyer & Zircon Medtech, subsequent Sales. Our core team consist of Regulatory, Project Management, Business Development, Logistics and Accounts department
The Company shall establish and maintain high standards of quality for its products, meeting cGMP norms. Products shall be manufactured and marketed in compliance with quality parameters related to identity, purity and safety
We are one stop solution for wide range of pharmaceutical products which covers Antibiotic, Anti-infective, Oncology, Human Blood products, Cardio-Diabetic, Anesthesia, and many more.
Our products have world class packing which gives goods visual appearance and at the same time it ensures product efficacy is maintained throughout the shelf life of the product.
We take care of individual requirements and ensure that a product tailored to your necessity is manufactured With the help of our trusted & strong network in the overseas countries.
Indian State FDA, MSME Udyog Aadhar Registered, Government recognized export house. We have manufacturing partners accredited with WHO-GMP, PICS, EU-GMP, PPB and more.
You can rely on our knowledgeable experts to help you efficiently and promptly register your pharmaceutical or API product in India.
Our method can assist in releasing a high-quality product that can enhance quality of life and pave the way for success.
Product Management Professionals must adapt new skills, learn new techniques to position and deliver success of the brands
Due to the risk of non-compliance and other threats to the pharamaseuticals company, drug developers should thoroughly understand them
Effective pharma business development strategies prioritize which goals the company needs to achieve for long term objectives
Our team is skilled and experienced to address the challenges burdening the healthcare industry and offers end-to-end tech-based solutions
FDA-registered and regulated pharmaceutical producer zircon Medtech is situated in India and follows Good Medicine Practice's. We prefer to think of ourselves as a more forward-thinking business that prioritises patient health and creates better pharmaceuticals to address their requirements.
Speak with your prescribing doctor if you experience any reaction after using the medication.
For minor adverse reactions, such as skin irritation, redness, or blisters, seek medical attention or call the Help line. If you experience shortness of breath, chest pains, swelling of the tongue, or any other serious effects, seek emergency care immediately.
We provide primary and secondary packaging in the following formats to markets including pharmaceuticals (Rx, OTC), personal care, nutritionals, medical devices, and veterinary care: bottle filling, blister packaging, pouching, repackaging, cold chain packaging, folding carton production, and compliance packaging. In addition to contract manufacturers and retail pharmacies, we also cater to the private label industry.
We are manufacturer, exporter & marketer of world class quality branded generic & generic medicine, located at Vadodara, City of Gujarat State, India. We offer contract manufacturing & In/Out licensing partnership model to our customers. We are also open for other partnership model based upon customer’s requirement.
ACCOUNT & FINANCE
CO-FOUNDER
PROJECT LEADER
CO-FOUNDER
Customer
Your staff was very attentive & helpful. I am very satisfied with your service. You have put together a great team that makes customers like me feel respected & valued. Thank you for your service.
Client
Zircon Medtech has by far the best products at my disposal…when one comes along like yours that is actually well researched and does its job well, it’s worth making a note and thanking someone!
Distributor
Zircon Medtech has been a trusted partner, helping clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market.
Oncology medicine supply from India to Brazil requires a clearly defined product specification before buyers compare quotations or confirm orders. A medicine name alone may not identify the required strength, formulation, container content or pack size. Two offers may refer to the same active ingredient while describing different products. One may quote a liquid concentrate in a single vial, while another lists a powder presentation or a pack containing several containers. A structured matching process helps buyers identify these differences, calculate purchasing quantities correctly and refer proposed alternatives for technical and regulatory review
Buyers sourcing ready brand medicine for Brazil should assess remaining shelf life before confirming quantities, prices and delivery schedules. A product may be available for immediate dispatch but have less usable time remaining than the buyer needs for import processing, distribution and customer demand. The expiry date alone does not show whether an order is commercially practical. Buyers also need to understand when the goods will arrive, when they can enter distribution and how quickly the proposed quantity is likely to be used. A structured shelf-life assessment helps buyers compare batch offers, identify unsuitable stock and agree on clear delivery requirements before placing an order.
A pharmaceutical injection exporter in India needs clear product and purchasing information to prepare a useful response to an international buyer. An enquiry that lists only a medicine name and asks for the best price often leaves important questions unanswered. The supplier may need to clarify the strength, concentration, container size, order quantity, destination market and documentation requirements before confirming availability or preparing a quotation. A detailed enquiry helps buyers compare offers consistently, identify supply limitations early and reduce avoidable communication before placing an order.
Ready brand pharmaceutical products from India can offer international buyers an opportunity to source medicines supplied under an existing brand. However, comparing suppliers requires more than checking a product catalogue and the price per pack. An attractive quotation may involve a minimum order quantity that exceeds expected demand. A short dispatch estimate may apply only to available stock, while another quotation includes a new production run. Differences in packaging, remaining shelf life and delivery terms can make apparently similar offers difficult to compare. Before placing an order, importers and distributors should establish exactly what quantity they must purchase, when that quantity will become available and when it can realistically reach the agreed destination.
Working with an oncology pharmaceutical exporter to Brazil requires planning beyond product selection, pricing and shipment arrangements. Importers and distributors also need to establish how product complaints, suspected quality defects and potential recalls will be managed after delivery. A concern may first reach a hospital, pharmacy, distributor or customer-service representative. Without an agreed reporting process, information can remain with the wrong organisation while potentially affected stock continues moving through the supply chain. Before placing an order, buyers should clarify who receives complaints, who investigates them, who coordinates Brazilian regulatory responsibilities and how affected batches can be traced.
Contacting a pharmaceutical injection exporter in India with a clear product enquiry helps buyers receive more relevant quotations and identify supply requirements early. A message asking only for “injection prices” leaves important details unanswered. The supplier may not know the required active ingredient, strength, presentation, quantity, destination market or documentation. For pharmaceutical importers, distributors and procurement teams, a detailed enquiry provides a practical starting point for assessing product suitability, commercial terms and the information needed before placing an order.
Trade margin rationalisation in India focuses on controlling specified margins within the medicine supply chain. Understanding how these margins are calculated helps pharmaceutical buyers, distributors and retailers interpret prices and compare commercial offers more accurately. Medicines may pass through manufacturers, stockists, distributors and pharmacies before reaching patients. Prices can change at each stage, reflecting commercial arrangements and distribution costs. However, trade margin and markup are different calculations. Confusing them can lead to incorrect pricing assumptions, particularly when interpreting a government announcement about a percentage cap.
Choosing a cancer medicine exporter in India involves reviewing more than product availability, pricing and delivery schedules. International buyers also need to understand where the medicines originate, which batches are supplied and how those batches can be traced after delivery. Oncology medicines may pass through several organisations, including manufacturers, exporters, logistics providers, importers and local distributors. Clear records help connect the product received by the buyer with its manufacturing source and subsequent distribution. Batch traceability supports this process by linking medicines to identifiable batches and relevant records. For international buyers, it provides a practical foundation for checking documentation, investigating complaints and responding to product recalls.
Oncology medicine export from India to Brazil involves more than selecting a product and arranging international delivery. Importers must evaluate the manufacturer, confirm the applicable regulatory pathway, review product documentation and establish suitable storage and transport arrangements. Cancer medicines may include oral tablets, capsules, injectable products and biological medicines. Each product can have different requirements for manufacturing evidence, registration, handling and ongoing safety monitoring. For Brazilian pharmaceutical importers and distributors considering Indian suppliers, a structured evaluation helps identify gaps before making commercial commitments. Quality, documentation and supply planning should be reviewed together from the beginning.
Pharmaceutical companies often work with international partners to develop products, expand their portfolios and enter new markets. These partnerships may involve access to pharmaceutical technologies, product data, trademarks, manufacturing knowledge or commercial rights. Pharmaceutical in-licensing and out-licensing describe two sides of a licensing arrangement. One company obtains defined rights, while another grants those rights under agreed conditions. For manufacturers, pharmaceutical businesses and international distributors, understanding these arrangements is an important part of evaluating a potential partnership. A suitable agreement should clearly define the rights involved, commercial terms, regulatory responsibilities and practical requirements for supplying the product.
